Business

November 13, 2013

BioDelivery Sciences loss widens in third quarter as drug research costs rise

BioDelivery Sciences International reported Tuesday that it had a net loss of $18.4 million in the third quarter, up from $17.4 million during the same period a year ago.

Related content

Comments

Editor's Choice Videos